COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: A 6-month prospective study

During the coronavirus disease 2019 (COVID-19) pandemic, exploring insulin resistance and β-cell activity is important for understanding COVID-19-associated new-onset diabetes. This study aimed to assess insulin sensitivity and fasting insulin secretion in COVID-19 patients without diabetes on admission and at 3 and 6 months after discharge.

Read the full article here

Related Articles